title: Renoprotective effects of incretin-based drugs: A novel pleiotropic effect of dipeptidyl peptidase-4 inhibitor.
authors.affiliation: Center for Innovative Clinical Medicine Okayama University Hospital Okayama Japan.
authors.forename: Ryo
authors.initials: R
authors.lastname: Kodera
authors.affiliation: Center for Innovative Clinical Medicine Okayama University Hospital Okayama Japan.
authors.forename: Kenichi
authors.initials: K
authors.lastname: Shikata
mesh_terms: D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000378:metabolism; D003928:Diabetic Nephropathies / Q000378:metabolism / Q000517:prevention & control*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use; D054795:Incretins / Q000494:pharmacology / Q000627:therapeutic use*; D007668:Kidney / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology
chemical_list: D054873:Dipeptidyl-Peptidase IV Inhibitors; D007004:Hypoglycemic Agents; D054795:Incretins
references.citation: Atherosclerosis. 2010 Dec;213(2):429-35
references.pmid: 20843518
references.citation: PLoS One. 2011;6(11):e27861
references.pmid: 22125632
references.citation: Biochem Biophys Res Commun. 2014 Jan 17;443(3):828-33
references.pmid: 24342619
references.citation: J Gastroenterol. 2014 Mar;49(3):481-91
references.pmid: 23475323
references.citation: Diabetes. 2014 Jun;63(6):2120-31
references.pmid: 24574044